# AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
> **ANDA217279** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2025-05-22
## Drug
- **FDA Application Number:** ANDA217279
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
- **Generic name:** AMLODIPINE AND ATORVASTATIN
- **Active ingredients:** AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2025-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217279)
---
*AI Analytics · CC0 1.0*